Kymera Therapeutics获得新型STAT6抑制剂专利
Kymera Therapeutics patents new STAT6 inhibitors
生物技术与制药领域的最新动态
Kymera Therapeutics patents new STAT6 inhibitors
Eli Lilly divulges new RXFP1 agonists
US scientists describe new c-Raf inhibitors
New EGFR inhibitors disclosed in Schrodinger patent
Boehringer Ingelheim discovers new cGAS inhibitors
Blueprint Medicines patents new CDK4 degradation inducers
Gluetacs Therapeutics divulges new protein degradation inducers
Blossomhill Therapeutics describes new macrocyclic compounds
New YAP1/TEAD interaction inhibitors disclosed in Hansoh patent
Brenig Therapeutics discovers new LRRK2 inhibitors
In the clinic for Nov. 26, 2025
Other news to note for Nov. 26, 2025
Regulatory actions for Nov. 26, 2025
Money raised by biopharma
Biopharma money raised: Jan. 1-Nov. 25, 2025